ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2026
Modification of the Transcription Factor FOXL2 at Serines 101 and 107 Disables DNA Binding, Leads to Nucleolar Relocalization, and Rewires Granulosa-Cell Programs.
Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
FOXL2 is a forkhead transcription factor (TF) essential for granulosa-cell identity and function, yet how post-translational modifications tune its activity remains incompletely understood. Here, we show that protein kinase C (PKC) phosphorylates FOXL2 in vitro. Two of the four phosphorylation sites, notably Ser101 and Ser107, map to the forkhead DNA-recognition helix. Phosphomimetic substitutions (S → D) at these positions (S101D/S107D) abolish binding to a consensus DNA sequence recognized by FOXL2 and luciferase reporter activation, whereas alanine substitutions are rather neutral. In HeLa cells, the S101D mutant and, to a lesser extent, S107A/S107D, relocalize at least partially to nucleoli and exhibit increased mobility consistent with reduced DNA engagement. This pattern was recapitulated in stably transduced KGN granulosa cells. RNA-seq of such KGN cells revealed that S101D and a C-terminal truncation (ΔC) induce a massive loss-of-function (LOF) relative to wild-type (WT) FOXL2. The LOF affects sets of genes involved in pathways central to granulosa physiology including ECM organization, cell migration/adhesion, and MAPK cascades, whereas S101A is largely WT-like. An analysis of the FOXL2 interactome in the transduced cells by mass spectrometry (MS) showed that S101D loses numerous interactions with TFs and chromatin remodelers, and Pol I/III regulators such as UBTF and TFIIIC components, while it gains other partners. By contrast, ΔC retains many of the protein-protein contacts of WT and preferentially loses ribosomal/TFIII interactions. Together, these data allow us to hypothesize that PKC-dependent phosphorylation within the FOXL2 DNA-recognition helix would underlie a rapid, reversible switch, weakening DNA binding, redirecting subnuclear partitioning, and rewiring protein-protein interactions, thereby reshaping FOXL2-dependent gene regulation in granulosa cells.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.